On November 14, 2014, Lipocine Inc. announced that it has terminated the employment of Dr. Srinivasan Venkateshwaran, Chief Technology Officer and Vice President Research & Development, and Gerald Simmons, Corporate Business Development Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | -0.91% | +13.74% | +134.41% |
09/05 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
09/05 | Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+134.41% | 3.5Cr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.39TCr | |
-3.09% | 2.16TCr | |
-10.65% | 1.9TCr | |
-13.41% | 1.63TCr | |
-40.50% | 1.7TCr | |
+6.64% | 1.41TCr | |
+31.84% | 1.2TCr |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine Inc. Announces Board Resignations